Literature DB >> 8063538

Cigarette smoking: effects on cognitive functions and drug-induced parkinsonism in chronic schizophrenia.

R Sandyk1.   

Abstract

Epidemiological studies suggest an apparent protective effect of cigarette smoking on the risk of Parkinson's disease. There is also a report suggesting that patients with Parkinson's disease who smoke are less likely to develop dementia. I investigated the relationship of smoking to the severity of cognitive functions and presence of drug-induced parkinsonism in a group of 111 neuroleptic-treated chronic institutionalized schizophrenic patients. Patients who smoked had significantly less cognitive impairment (p < .02) and a lower prevalence of drug-induced Parkinsonism (p < .02) compared to nonsmokers. These findings suggest that cigarette smoking may protect against the development of dementia and drug-induced Parkinsonism in schizophrenia.

Entities:  

Mesh:

Year:  1993        PMID: 8063538     DOI: 10.3109/00207459309000574

Source DB:  PubMed          Journal:  Int J Neurosci        ISSN: 0020-7454            Impact factor:   2.292


  7 in total

Review 1.  Movement disorders: neurodevelopment and neurobehavioural expression.

Authors:  T Archer; R J Beninger
Journal:  J Neural Transm (Vienna)       Date:  2006-10-06       Impact factor: 3.575

Review 2.  Drug-induced parkinsonism in the elderly: incidence, management and prevention.

Authors:  José Luis López-Sendón; María Angeles Mena; Justo García de Yébenes
Journal:  Drugs Aging       Date:  2012-02-01       Impact factor: 3.923

3.  Neuroadaptations to chronic exposure to drugs of abuse: relevance to depressive symptomatology seen across psychiatric diagnostic categories.

Authors:  Athina Markou; Paul J Kenny
Journal:  Neurotox Res       Date:  2002-06       Impact factor: 3.911

4.  Nicotine consumption during the prodromal phase of schizophrenia - a review of the literature.

Authors:  Athanasios Gogos; Maria Skokou; Eleni Ferentinou; Philippos Gourzis
Journal:  Neuropsychiatr Dis Treat       Date:  2019-10-16       Impact factor: 2.570

5.  European network for promoting the physical health of residents in psychiatric and social care facilities (HELPS): background, aims and methods.

Authors:  Prisca Weiser; Thomas Becker; Carolin Losert; Köksal Alptekin; Loretta Berti; Lorenzo Burti; Alexandra Burton; Mojca Dernovsek; Eva Dragomirecka; Marion Freidl; Fabian Friedrich; Aneta Genova; Arunas Germanavicius; Ulaş Halis; John Henderson; Peter Hjorth; Taavi Lai; Jens Ivar Larsen; Katarzyna Lech; Ramona Lucas; Roxana Marginean; David McDaid; Maya Mladenova; Povl Munk-Jørgensen; Alexandru Paziuc; Petronela Paziuc; Stefan Priebe; Katarzyna Prot-Klinger; Johannes Wancata; Reinhold Kilian
Journal:  BMC Public Health       Date:  2009-08-28       Impact factor: 3.295

6.  Cholinergic receptor nicotinic beta 3 subunit polymorphisms and smoking in male Chinese patients with schizophrenia.

Authors:  Jing Shi; Nan Chen; Zhiren Wang; Fan Wang; Yunlong Tan; Shuping Tan; Jinghui Tong; Huimei An; Xiaoyun Guo; Lingjun Zuo; Xiaoping Wang; Fude Yang; Xingguang Luo
Journal:  EC Psychol Psychiatr       Date:  2021-06-28

7.  Antipsychotic medication and tobacco use among outpatients with schizophrenia: a cross-sectional study.

Authors:  Hiranya Wijesundera; Raveen Hanwella; Varuni A de Silva
Journal:  Ann Gen Psychiatry       Date:  2014-03-19       Impact factor: 3.455

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.